Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference
Axogen (NASDAQ: AXGN) will participate in the 2026 Bank of America Global Healthcare Conference and present on Wednesday, May 13, 2026 at 9:35 AM PT.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Axogen (NASDAQ: AXGN) will participate in the 2026 Bank of America Global Healthcare Conference and present on Wednesday, May 13, 2026 at 9:35 AM PT. A live audio webcast will be available via the company’s Investors website at ir.axogeninc.com.
Details
News Market Reaction – AXGN
On Apr 30, the day this news came out, AXGN closed 3.42% above the previous close.
Data tracked by StockTitan Argus for the Apr 30 session.
Key Figures
- Conference date
- May 13, 2026
- Bank of America Global Healthcare Conference presentation date
- Presentation time
- 9:35 AM PT
- Scheduled time for Axogen management presentation
- Announcement date
- April 30, 2026
- Press release date for conference participation
Historical Context
-
Q1 2026 beat with 26.6% revenue growth and raised full-year guidance.
-
Announcement of Q1 2026 results date and investor call details.
-
Strong Q4 and 2025 growth plus equity offering and debt repayment.
-
Participation in three early‑March 2026 investor conferences.
-
Planned Q4 and full‑year 2025 results release and webcast details.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
peripheral nerve medical
nasdaq financial
webcast technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
ALACHUA, Fla. and TAMPA, Fla., April 30, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that the company will be participating in the upcoming 2026 Bank of America Global Healthcare Conference.
Axogen’s management is scheduled to present on Wednesday, May 13, 2026, at 9:35 AM PT. Interested parties may access a live audio webcast of the presentation by visiting the “Investors” section of the company’s website at ir.axogeninc.com.
About Axogen
Axogen (AXGN) is the leading company focused specifically on the science, development and commercialization of technologies for peripheral nerve regeneration and repair. Axogen employees are passionate about providing the opportunity to restore nerve function and quality of life for patients with peripheral nerve injuries by providing innovative, clinically proven and economically effective repair solutions for surgeons and healthcare providers. Peripheral nerves provide the pathways for both motor and sensory signals throughout the body. Every day people suffer traumatic injuries or undergo surgical procedures that impact the function of their peripheral nerves. Physical damage to a peripheral nerve or the inability to properly reconnect peripheral nerves can result in the loss of muscle or organ function, the loss of sensory feeling, or the initiation of pain.
Axogen’s product portfolio includes Avance® (acellular nerve allograft-arwx), Avance® Nerve Graft, Axoguard Nerve Connector®, Axoguard Nerve Protector®, Axoguard HA+ Nerve Protector™, Axoguard Nerve Cap®, and Avive+ Soft Tissue Matrix™.
Contact:
Axogen, Inc.
InvestorRelations@axogeninc.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.